Chad Verbowski will retire from Confluent, Inc. (“Confluent”) as Chief Technology Officer effective as of November 26, 2024, in order to take a career break.
Departed
Mahesh Karande
President and Chief Executive Officer
Omega Therapeutics, Inc.
Effective
2024-11-14
Successor
Kaan Certel
Filed
November 14, 2024, 6:59 PM ET
On November 14, 2024 (the " Transition Date "), Mahesh Karande tendered his resignation as President and Chief Executive Officer and as a member of the Board of Directors (the " Board ") of the Company, effective immediately.
On November 13, 2024, John G. Morikis, Executive Chairman of the Board of Directors (the “Board”) of The Sherwin-Williams Company (“Sherwin-Williams”), notified Sherwin-Williams of his decision to retire from his position as Executive Chairman, effective as of the close of business on December 31, 2024.
On November 13, 2024, Jane M. Cronin, Senior Vice President – Enterprise Finance (principal accounting officer) (“SVP – Enterprise Finance”) of Sherwin-Williams, notified Sherwin-Williams of her decision to retire from her position as SVP – Enterprise Finance, effective as of the close of business on December 31, 2024.
Departed
Kirk Coleman
Chief Financial Officer
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Successor
Craig R. Jalbert
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Kirk Coleman and Zamaneh Mikhak, Ph.D., ceased serving as President/Chief Executive Officer, Chief Financial Officer and Chief Medical Officer, respectively, to be effective as of November 14, 2024.
Departed
Zamaneh Mikhak
Chief Medical Officer
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Kirk Coleman and Zamaneh Mikhak, Ph.D., ceased serving as President/Chief Executive Officer, Chief Financial Officer and Chief Medical Officer, respectively, to be effective as of November 14, 2024.
Departed
Harlan Weisman
President/Chief Executive Officer
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Successor
Craig R. Jalbert
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Kirk Coleman and Zamaneh Mikhak, Ph.D., ceased serving as President/Chief Executive Officer, Chief Financial Officer and Chief Medical Officer, respectively, to be effective as of November 14, 2024.
Departed
Brandi Roberts
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Departed
Thomas King
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Departed
Harlan Weisman
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Departed
Stephen Rocamboli
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Departed
Catherine Lee
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Departed
Robert J. Mills
Member of the Board
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
On November 7, 2024, W. Andrew Adams notified National HealthCare Corporation (the “Company”) that, after 32 years of service, he intends to retire as a member of the Company Board of Directors (the “Board”) effective at the conclusion of the 2025 annual meeting of shareholders to be held on May 8, 2025.
Departed
Linda Stacy
Secretary, Principal Financial Officer, and Principal Accounting Officer
On November 8, 2024, Linda Stacy, Secretary, Principal Financial Officer, and Principal Accounting Officer of National Research Corporation (the “Company”), notified the Company of her decision to retire effective December 31, 2024.
On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.
On November 11, 2024, Brian Mitts resigned effective as of 11:59 p.m. Central Time on December 31, 2024 from his positions as Chief Financial Officer, Executive Vice President-Finance, Secretary and Treasurer of NexPoint Real Estate Finance, Inc.
Departed
Brian Mitts
Chief Financial Officer, Executive VP-Finance, Secretary and Treasurer
Brian Mitts resigned effective as of 11:59 p.m. Central Time on December 31, 2024 from his positions as Chief Financial Officer, Executive VP-Finance, Secretary and Treasurer of NexPoint Residential Trust, Inc.
Departed
Brian Mitts
Chief Financial Officer, Executive VP-Finance, Treasurer and Assistant Secretary
On November 11, 2024, Brian Mitts resigned effective as of 11:59 p.m. Central Time on December 31, 2024 from his positions as Chief Financial Officer, Executive VP-Finance, Treasurer and Assistant Secretary of NexPoint Diversified Real Estate Trust
On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.
On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.
Zillow announced that Susan Daimler will depart her role as President of Zillow effective immediately, and she will depart Zillow as further described below.
On November 12, 2024, Dag Skindlo announced to the board of directors (the “Board”) of the Company his intention to resign with immediate effect.
Departed
Brian Mitts
President
VINEBROOK HOMES TRUST, INC.
Effective
2024-12-31
Successor
John Good
Filed
November 14, 2024, 6:59 PM ET
On November 11, 2024, Brian Mitts resigned effective as of 11:59 p.m. Central Time on December 31, 2024 from his position as President of VineBrook Homes Trust, Inc.
Departed
Rebecca Macieira-Kaufmann
Director
Everest Consolidator Acquisition Corp
Effective
2024-11-23
Filed
November 14, 2024, 6:59 PM ET
On November 6, 2024, Rebecca Macieira-Kaufmann resigned as a member of the Board of the Company, effective November 23, 2024.
Departed
Jacqueline S. Shoback
Chief Operating Officer
Everest Consolidator Acquisition Corp
Effective
2024-11-23
Filed
November 14, 2024, 6:59 PM ET
On November 6, 2024, Jacqueline S. Shoback resigned as Chief Operating Officer and as a member of the Board of Directors (the “Board”) of Everest Consolidator Acquisition Corporation (the “Company”), effective November 23, 2024.
Departed
Peter K. Scaturro
Director
Everest Consolidator Acquisition Corp
Effective
2024-11-23
Filed
November 14, 2024, 6:59 PM ET
On November 6, 2024, Peter K. Scaturro resigned as a member of the Board of the Company, effective November 23, 2024.
Departed
Elizabeth Mora
Director
Everest Consolidator Acquisition Corp
Effective
2024-11-23
Filed
November 14, 2024, 6:59 PM ET
On November 6, 2024, Elizabeth Mora resigned as a member of the Board of the Company, effective November 23, 2024.
On November 13, 2024, Jeh C. Johnson notified the Board of Directors of Lockheed Martin Corporation (the “Company”) that he was resigning from the Board of Directors, effective November 13, 2024.
Christopher Geberth, Chief Financial Officer of Allurion Technologies, Inc. (the “Company”), notified the Company of his decision to resign, effective as of the close of business on November 13, 2024, to pursue other interests.
On November 8, 2024, James Chung, M.D., Ph.D., Chief Medical Officer of the Company, resigned from the Company, to be effective as of November 22, 2024.
On October 1, 2024, Dave Bruce was terminated as the Company’s Chief Executive Officer (the “CEO”) and principal executive officer, effective immediately
Mr. Maffei, the President and Chief Executive Officer, and a member of the Board of Directors of Liberty Broadband, notified Liberty Broadband that he will be stepping down from these roles at the end of 2024.
Departed
Michael Glimcher
Chief Executive Officer and President
BGO Industrial Real Estate Income Trust, Inc.
Effective
2024-12-31
Successor
Clint Hinds
Filed
November 13, 2024, 6:59 PM ET
Mr. Glimcher delivered his notice of resignation to the Board on November 6, 2024, with an effective date of December 31, 2024 or such earlier date with notice thereof.
Departed
Alisher Nurmat
Vice President Accounting and Treasurer (principal accounting officer)
On November 7, 2024, Alisher Nurmat announced his intention to retire from his position of Vice President Accounting and Treasurer (and principal accounting officer) of Gevo, Inc. (the “Company”), effective November 21, 2024.
This appointment was made in connection with the retirement of Mr. Birzer from the Board of Directors of TYG and TEAF effective at the close of business on December 31, 2024.
Mr. Quintana and Mr. Anderson resigned from the Board as chairman and director and as director, respectively
Departed
Lloyd Waterhouse
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
Erik Akopiantz
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
Brian Jaffee
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
Ossa Fisher
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
Holden Spaht
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
Charles Goodman
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Departed
James Hutter
director
INSTRUCTURE HOLDINGS, INC.
Effective
2024-11-13
Filed
November 13, 2024, 6:59 PM ET
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
On November 8, 2024, following her election as governor of New Hampshire, Kelly A. Ayotte, a member of the board of directors (the “Board”) of Blackstone Inc. (“Blackstone”), notified Blackstone of her intention to resign from the Board.
Departed
Lawrence D. McGovern
Chief Financial Officer
HERITAGE COMMERCE CORP
Effective
2025-02-15
Successor
Thomas A. Sa
Filed
November 13, 2024, 6:59 PM ET
Mr. McGovern will depart on or about February 15, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.